GP

Garima Pendharkar

Active Director Director DIN 11019622
DIN 11019622 First appointment Mar 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Garima Pendharkar

Data last updated:

Garima Pendharkar is a Director at Skyalcy Healthcare Private Limited (since 2025) and Director at Delavie Kawai Life Science Private Limited (since 2025).

DIN 11019622
Primary Designation Director
First Appointment 25 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Skyalcy Healthcare Private Limited U46497PN2025PTC249116
Director10 Dec 20252025Active
Director25 Mar 20252025Active

Directorship timeline

Open interactive timeline →
Skyalcy Healthcare Private Limited
Delavie Kawai Life Science Private Limited
Premium access

Shareholding and investment profile for Garima Pendharkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Garima Pendharkar

Garima Pendharkar currently holds 2 directorships: Skyalcy Healthcare Private Limited (Director, since 10 Dec 2025); Delavie Kawai Life Science Private Limited (Director, since 25 Mar 2025).

Garima Pendharkar was first appointed on 25 Mar 2025 as Director at Delavie Kawai Life Science Private Limited.

The current boards of Garima Pendharkar's companies include Bhanu (Skyalcy Healthcare Private Limited), Anjali (Delavie Kawai Life Science Private Limited), Deepti Thakur (Delavie Kawai Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available